-
COVER STORY
Piramal – The unique needs of the HPAPI market: Are you prepared?
-
EDITORIAL
The power of collaboration and partnership in ensuring medicine quality
R. T. Piervincenzi
-
LATEST NEWS
Gene therapy hitting its stride as M&A slows and biosimilars challenge
J. Boggs
-
MARKET ACCESS
Navigating the barriers to successful market access
R. Galbraith, G. Jones
-
INTELLECTUAL PROPERTY
The trademarks for pharmaceutical products
G. Tagliafico, S. Venturini
-
COMPANY PROFILE
PharmaMar an innovative oncology company
-
COMPLIANCE
New requirements by the Belgian Sunshine Act apply to all medicinal products and medical devices
R. Carnà
-
REGULATORY
Key differences between the new Medical Device (MD) and the Over The Counter (OTC) regulations in Europe
A. L. Tardy
-
MERGERS & ACQUISITIONS
Notable life sciences Mergers & Acquisitions in Q3 2017
P. D'Souza
-
FOCUS ON CRO & CDMO
US: Contract services one year on
G. Roth
-
FOCUS ON CRO & CDMO
Clinical operations: technology is a vital resource
C. Buonamico
-
FOCUS ON CRO & CDMO
Serialisation: the path to compliance
E. Haeffler
-
PANEL DISCUSSION ON CRO & CDMO
-
COMPANY PROFILE
RTC – Project Design Regulatory Testing Bioanalytical services
-
PRODUCTS & SERVICES
-
EXCIPIENTS
Carboxymethyl starch – an excipient for drug chronodelivery Old excipients, new functionalities
P. Ispas-Szabo, M. Alexandru Mateescu
-
BUSINESS NEWS
-
DOSAGE FORM
Finer particles, consistent delivery. Utilising breath actuated mechanisms to improve the performance of dry powder inhalers
D. Lewis, A. Tweedie, F. Mason
-
MEDICAL DEVICES
The New Medical Device Regulation in ten points What are the challenges for manufacturers?
P. Rose
-
MARKETPLACE
Export controls: Little known risks for biopharma companies
E. R. Mc Clafferty, L. van der Meer
-
in & out
Click here to read the e-version of Vol. 1(4),
Recent Posts
- Olon: celebrating10 years of daptomycin and doubled production capacity
- Intertek Launches Pioneering Digital Platform iCare in India
- PolyPeptide participates in industry effort to advance sustainability
- Harnessing the Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges
- BORMIOLI PHARMA – Bormioli Pharma launches the 3rd edition of its ESG Report, reaching the 45% of sustainable materials in sold products with its EcoPositive range
